Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.
Journal: Blood cancer journal
Published: January 27, 2026
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 31, 2025
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.
Journal: American journal of hematology
Published: January 27, 2025
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers.
Journal: Haematologica
Published: June 06, 2024
Bispecific antibodies in the treatment of relapsed/refractory large B-cell lymphoma.
Journal: Expert review of anticancer therapy
Published: May 29, 2024
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms.
Journal: Cancer metastasis reviews
Published: May 12, 2024
The role of noncovalent BTK inhibitors in the era of covalent BTK inhibitors.
Journal: Clinical advances in hematology & oncology : H&O
Published: April 08, 2024
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma.
Journal: Transplantation and cellular therapy
Published: March 22, 2024
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning.
Journal: Bone marrow transplantation
Published: May 02, 2023
Last Updated: 09/26/2026